vimarsana.com

நாள்பட்ட சோர்வு சிகிச்சையகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

For young adults, chronic fatigue may follow COVID-19

Young adults and adolescents who get COVID-19 may also exhibit symptoms of a complex, multisystem disorder previously known as chronic fatigue syndrome, three new case studies show. With more of this age group being treated for COVID-19, clinicians are concerned they will start showing post-COVID or “long haul“ symptoms from their bouts with the virus. The review in Frontiers in Medicineprovides some of the first evidence that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), may be one serious post-COVID problem. “In the three patients studied all of whom had confirmed or highly probable COVID-19 infections early in the pandemic we observed ME/CFS-like symptoms within the first two weeks of illness,” says Peter Rowe, professor of pediatrics at Johns Hopkins University School of Medicine and director of the Chronic Fatigue Clinic at Johns Hopkins Children’s Center. “At six months following their illness, all three still met the criteria for being diagnosed

After a Slow Year, Fibromyalgia Research Ends on an Encouraging Note

ProHealth By Donna Gregory Burch • ProHealth.com • January 25, 2021 ( >2020 was a quiet year for the fibromyalgia community when compared to Lyme or ME/CFS. There were no major headlines, and yet thousands of researchers, physicians and advocates worked behind the scenes, inching toward better treatments, testing and quality of life for fibromyalgia patients. Below is a summary of some of the most important fibromyalgia-related news stories from the past year. These small but mighty advances should lead to even more progress during 2021. New Fibromyalgia Drugs Are in the Pipeline NYX-2925: In September, biopharmaceutical company Aptinyx, Inc. resumed patient recruitment for a phase 2 study of NYX-2925, a novel N-methyl-D-aspartate receptor modulator, after temporarily halting the trial in March due to the COVID-19 pandemic.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.